
The big one is finally out!! In this paper, we set out to provide insight into the fundamental question; How do the individual cells from complex tissues regulate their proteomes? Brief summary of our findings 👇 biorxiv.org/content/10.1101/…

Post-doc @slavovlab Interests: Non-canonical protein sequences Protein degradation Single cell analysis

The big one is finally out!! In this paper, we set out to provide insight into the fundamental question; How do the individual cells from complex tissues regulate their proteomes? Brief summary of our findings 👇 biorxiv.org/content/10.1101/…

Its fun spending probably upwards of 100 hours responding point by point to reviewers for either them not to even return the email for the revisions or respond in a few sentences that dont acknowledge any of the responses you made, its a really solid use of time!

Parallel Squared Technology Institute aims to scale the throughput of sensitive proteomics without compromising quantitative accuracy, depth or specificity. Today, we share a step in this direction: 🔹 A workflow supporting the analysis of 1,130 single-cell samples per day (SPD) while preserving depth and quantitative accuracy. 1/ biorxiv.org/content/10.1101/…

Got the results back from the first plasmid I design this morning! Anyone who has done this before would have found it trivial but to me it all felt like magic Getting into a new field is a great way to reinvigorate your excitement and passion for science

This gets particularly interesting in single cells from the same cell type. Working at the cell type level misses much of the action. 2/ biorxiv.org/content/10.1101/…

It’s indeed time to transition from mRNA and protein levels do not correlate.
Don't correlate is a weak statement, especially in the absence of independent measurements & reliability accounting. What's compelling for me are direct measurements of what regulates protein abundance. doi.org/10.1101/2025.02.10.6… 1/

No reason to take a hard stance on this! Certain mechanisms cause regulation by translation/protein clearance in certain contexts. We aim to discover these mechanisms partly through measuring protein dynamics in single cells :) biorxiv.org/content/10.1101/…
For everyone chiming in with "RNA and protein don't correlate"… here's some thoughts I wrote up on this point a while back:

Come join!
The Molecular Biosciences Department at Northwestern is excited to announce a faculty search for a Tenure-Track Assistant Professor position! Learn more and apply at: molbiosci.northwestern.edu/f… #BiologyJobs #AcademicJobs #FacultySearch #FacultyJobs

Pretty photo of our powerful droplet sample preparation method for multiplexed single cell proteomics!
The piece revisits the early days, our lab's initial work alongside other groups pioneering complementary approaches, together showing that mass-spec-based single-cell proteomics was feasible & promising. The proof-of-concept set the field in motion. 2/ nature.com/articles/d41586-0…

The piece revisits the early days, our lab's initial work alongside other groups pioneering complementary approaches, together showing that mass-spec-based single-cell proteomics was feasible & promising. The proof-of-concept set the field in motion. 2/ nature.com/articles/d41586-0…

Cells mitigate damage to DNA in surprising ways. Using a series of CRISPRi chemogenomics screens, we identified a PRDX1-dependent iron–damage axis in the DNA damage response. Congratulations to Tom, Abe, Shaheen, Josep and all co-authors! doi.org/10.1038/s41589-026-0…

The progress on pushing a new paradigm for multiplexing MS has been amazing. Shorter LC gradients are great but will run into fundamental limits. The creative multifaceted solutions the developed will open new doors for accessability of SCP / type of experiments that can be done
Accurately quantifying over 700K precursors in a single 9-plexDIA set of 20ng proteomes is a new milestone. JMod achieves high quantitative accuracy over a 32-fold dynamic range of proteome spiked-in ratios across single-cell and bulk sample sizes. 1/ doi.org/10.1101/2025.05.22.6…

Claude Science when it becomes a wrapper on existing tools
Many drugs work by binding to a specific target in the body and blocking or changing what it does. An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or months of expert work per target, sifting through a large number of candidates to identify the few that work. We wanted to test if Claude could successfully design novel protein binders from scratch (also called de novo design). With a protein design prompt written by a human expert, Claude autonomously designed protein binders against 14 out of 15 targets. We then worked with Adaptyv Bio and Twist Bioscience, who independently built and tested the proteins Claude designed.

This analysis extended previous trends observed across cell types, where growth rate dictates the extent of control by protein degradation, to our identified gradient of growth within a cell type.

We updated our single cell in vivo metabolic labeling preprint partly thanks to constructive feedback from reviewers. In the added analysis, we identified a gradient of proliferation within Basal epithelial cells corresponding to Krt13+ hillock cells. biorxiv.org/content/10.1101/…

I made a mistake in the figure below and the result is actually a lot stronger (and makes much more sense, brain should clearly have slower turnover than the other tissues). Thanks @Yanshen73854711 for generating awesome data!
In this revision, we expanded our analysis across more tissue types & more model systems. The conclusions held. Proteomes are shaped by tissue type-specific protein degradation rates ▶️ This effect strongly depends on the cell growth rates. 🔗biorxiv.org/content/10.1101/…